Brainstorm Cell Therapeutics BCLI Clinical Stage Biotech

Brainstorm Cell Therapeutics is a clinical-stage biotechnology company pioneering autologous cell therapies for neurological disorders, with a focus on ALS and MS. The company's flagship product, NurOwn®, is an innovative autologous cell therapy platform designed to treat neurodegenerative diseases. The company leverages decades of expertise in cell therapy and biopharma commercialization under experienced leadership.